Dalal RS, Carlin A, Cabral H, Hardwick GB, et al. Real-World Comparative Effectiveness of Vedolizumab Versus Upadacitinib for Crohn's Disease Through 52 Weeks. J Clin Gastroenterol 2025 Dec 19. doi: 10.1097/MCG.0000000000002309.
PMID: 41411531